Cargando…

Features of steroidogenesis in men with hypogonadism and type 2 diabetes

BACKGROUND: BACKGROUND: Type 2 diabetes mellitus (DM2) in men is associated with a high incidence of hypogonadism. Testosterone is a steroid hormone and one of the final metabolites of steroidogenesis, which causes interest in assessing the content of key steroid hormones, their precursors and metab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rozhivanov, R. V., Chernova, M. O., Ioutsi, V. A., Mel’nichenko, G. A., Shestakova, M. V., Mokrysheva, N. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrinology Research Centre 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762540/ https://www.ncbi.nlm.nih.gov/pubmed/35841175 http://dx.doi.org/10.14341/probl13129

Ejemplares similares

The role of glucose and insulin in the metabolic regulation of growth hormone secretion
por: Sorkina, E. L., et al.
Publicado: (2021)

Serum Vitamin D Metabolites by HPLC-MS/MS Combined with Differential Ion Mobility Spectrometry: Aspects of Sample Preparation without Derivatization
por: Usoltseva, Liliia, et al.
Publicado: (2023)

Assessment of Vitamin D Metabolism in Patients with Cushing’s Disease in Response to 150,000 IU Cholecalciferol Treatment
por: Povaliaeva, Alexandra, et al.
Publicado: (2021)

Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation
por: Shestakova, M. V., et al.
Publicado: (2022)

Clinicopathologic assessment of hypogonadism in men with type 2 diabetes mellitus
por: Ugwu, Theophilus E., et al.
Publicado: (2016)

Improvement of Testicular Steroidogenesis Using Flavonoids and Isoflavonoids for Prevention of Late-Onset Male Hypogonadism
por: Martin, Luc J., et al.
Publicado: (2020)

IDF21-0416 Mortality risk factors due to COVID-19 in diabetic patients according to the nationwide diabetes register analysis
por: Shestakova, M., et al.
Publicado: (2022)

Lower circulating kisspeptin and primary hypogonadism in men with type 2 diabetes
por: Asare‐Anane, Henry, et al.
Publicado: (2019)

Munchausen syndrome with factitious hypoglycemia due to deliberate insulin analog administration and factitious hyperglycemia in a patient with hypothyroidism
por: Yukina, Marina, et al.
Publicado: (2022)

The Incidence of Hypogonadotropic Hypogonadism in Type 2 Diabetic Men in Polish Population
por: Rabijewski, Michał, et al.
Publicado: (2013)

Clinical and biochemical correlates of hypogonadism in men with type 2 diabetes mellitus
por: Musa, Ezekiel, et al.
Publicado: (2021)

Development of destructive thyroiditis and diabetes mellitus after three injections of pembrolizumab for skin melanoma
por: Glibka, A. A., et al.
Publicado: (2021)

Depression in Nonclassical Hypogonadism in Young Men
por: Korenman, Stanley G, et al.
Publicado: (2018)

Male hypogonadism: 14‐year prospective outcome in 550 men with type 2 diabetes
por: Malipatil, Nagaraj S., et al.
Publicado: (2019)

Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
por: Jones, T. Hugh, et al.
Publicado: (2011)

Prevalence of hypogonadism in male Type 2 diabetes mellitus patients with and without coronary artery disease
por: Madhu, S. V., et al.
Publicado: (2017)

Effects of liraglutide on obesity-associated functional hypogonadism in men
por: Jensterle, M, et al.
Publicado: (2019)

The Effects of Separate and Combined Treatment of Male Rats with Type 2 Diabetes with Metformin and Orthosteric and Allosteric Agonists of Luteinizing Hormone Receptor on Steroidogenesis and Spermatogenesis
por: Bakhtyukov, Andrey A., et al.
Publicado: (2021)

Hypogonadotropic hypogonadism in men with hereditary hemochromatosis
por: El Osta, Rabih, et al.
Publicado: (2017)

Induction of spermatogenesis in men with hypogonadotropic hypogonadism
por: Morris, Guy C., et al.
Publicado: (2021)

Effect of soy on bone turn-over markers in men with type 2 diabetes and hypogonadism – a randomised controlled study
por: Sathyapalan, T., et al.
Publicado: (2017)

Assessment of Hypogonadism in Men With Type 2 Diabetes: A Cross-Sectional Study From Saudi Arabia
por: Al Hayek, Ayman Abdullah, et al.
Publicado: (2017)

Hypogonadism in Human Immunodeficiency Virus-Positive Men
por: Ashby, Jane, et al.
Publicado: (2014)

Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men
por: Lunenfeld, Bruno, et al.
Publicado: (2015)

Cardiometabolic indices predict hypogonadism in male patients with type 2 diabetes
por: Caretta, N., et al.
Publicado: (2022)

Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol
por: Russo, Vittoria, et al.
Publicado: (2021)

Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
por: Sansone, A., et al.
Publicado: (2021)

The Role of Diet and Weight Loss in Improving Secondary Hypogonadism in Men with Obesity with or without Type 2 Diabetes Mellitus
por: Giagulli, Vito Angelo, et al.
Publicado: (2019)

Effects of Bisphenols on Testicular Steroidogenesis
por: Barbagallo, Federica, et al.
Publicado: (2020)

Klinefelter syndrome (KS): genetics, clinical phenotype and hypogonadism
por: Bonomi, M., et al.
Publicado: (2016)

The effectiveness of zinc supplementation in men with isolated hypogonadotropic hypogonadism
por: Liu, Yan-Ling, et al.
Publicado: (2017)

Can we recommend varicocele surgery for men with hypogonadism?
por: Marquardt, Nilson, et al.
Publicado: (2023)

The prevalence of hypogonadism in diabetic men in Isfahan Endocrine and Metabolism Research Center, Isfahan, Iran
por: Mirzaei, Mohammad Reza, et al.
Publicado: (2012)

Chemical suppression of steroidogenesis.
por: Colby, H D
Publicado: (1981)

MON-275 Prolactin to Testosterone Ratio Predicts Pituitary Pathology in Hypogonadal Men with Mild Hyperprolactinemia
por: Naelitz, Bryan D, et al.
Publicado: (2020)

Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss
por: Yassin, AA, et al.
Publicado: (2013)

Risk Factors for Hypogonadism in Male Patients with Type 2 Diabetes
por: Zheng, Rendong, et al.
Publicado: (2016)

Frequency of Hypogonadism and Erectile Dysfunction in Type-II Diabetic Patients
por: Mushtaq, Samsam, et al.
Publicado: (2018)

Impact of hypogonadism on bone mineral density and vertebral fractures in HIV-infected men
por: Pezzaioli, L. C., et al.
Publicado: (2021)

SUN-LB114 Remission of Type 2 Diabetes (DMT2) in Hypogonadal Men Under Long-Term Testosterone Therapy
por: Mskhalaya, George, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cvfcadt9mg78jj79oadd6u7pn9